The cytokine storm is still a relatively recent discovery, scientifically speaking, and is actively being studied. ProSci enhances this type of research through supplying high-performance antibodies and recombinant proteins for investigating IFNs, ILs, TNF, chemokines, CSF and growth factors.
To support the investigation of SARS-CoV-2 variants, The Native Antigen Company offers a growing range of recombinant mutant spike antigens.
Researchers have found antibodies capable of neutralising tick-borne encephalitis (TBE), a viral infectious disease transmitted by tick bites.
Aves Labs' anti-green fluorescent protein antibody (GFP) is a highly cited chicken polyclonal antibody, having gained over 1300 citations worldwide.
Abcam's recombinant antibodies overcome the limitations of traditional antibody production to provide a high level of consistency between batches, reproducibility, confirmed specificity and a long-term supply.
AdipoGen Life Sciences' anti-Fas clones APO-1-3 and APO-1-1 are monoclonal antibodies that recognise human Fas and are capable of inducing Fas-mediated apoptosis.
Loading a cancer immunotherapy drug onto a metal–organic framework improves both its delivery and its sustained release for treating leukaemia.
Researchers have developed a method that fast-tracks the passage of biopharmaceuticals from the lab to clinical trials — from as long as two years to just six months.
The antibody has been validated for use in flow cytometry, immunocytochemistry and immunohistochemistry with both frozen and paraffin-embedded tissue samples.
Proteintech's monoclonal and polyclonal antibodies are now available directly conjugated with fluorescent dyes: CoraLite488, CoraLite594 and CoraLite647. They act as useful tools for immunofluorescence studies requiring multiplex co-labelling studies without the need for secondary antibodies.
ViroStat has released several monoclonal antibodies to the Marburg virus — one of the causes of viral haemorrhagic fever.
GeneTex's SARS-CoV/SARS-CoV-2 (COVID-19) spike antibody [1A9] detects both SARS-CoV spike and SARS-CoV-2 spike proteins.
AdipoGen Life Sciences offers a broad range of microtubule research solutions. This includes tubulin-specific antibodies, unique and validated post-translational modification-specific antibodies and Rab1-GTP and Rab6-GTP specific antibodies.
SYnAbs produces innovative monoclonal antibodies against poor immunogenic compounds and complex antigens.
The ability to accurately characterize the immune response against SARS-CoV-2 is of vital importance in managing the current COVID-19 pandemic.